Polaryx Therapeutics IPO: Rare Disease Biotech Set for Nasdaq Listing
US-based biotechnology company Polaryx Therapeutics is preparing to enter the stock market through a direct listing on the…
US-based biotechnology company Polaryx Therapeutics is preparing to enter the stock market through a direct listing on the…